Four former GlaxoSmithKline employees will share up to $250m (£159m) after their evidence helped US authorities secure a record settlement with the UK drug company for mispromoting drugs
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Glaxo whistleblowers to share $250m windfall
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account